Abstract
AbstractWe evaluated a digital cognitive assessment platform, Philips IntelliSpace Cognition, in a cross-sectional cohort of patients diagnosed with mild cognitive impairment (MCI). Performance on individual neuropsychological tests, cognitive domain scores, and Alzheimer’s disease (AD) specific composite scores in MCI were compared with a cohort of cognitively normal adults (CN). The cohorts were matched for age, sex, and education. The performance on all but two neuropsychological tests was worse in the MCI group. After ranking the cognitive domains by effect size, we found that the memory domain was most impaired, followed by executive functioning. The Early AD/MCI Alzheimer’s Cognitive Composite (EMACC) and Preclinical Alzheimer’s Cognitive Composite (PACC) scores were constructed from the digital tests on Philips IntelliSpace Cognition. Both AD-specific composite scores showed greater sensitivity and specificity than the Mini-Mental State Examination, as well as individual neuropsychological tests and individual cognitive domain scores. Together, these results demonstrate the diagnostic value of Philips IntelliSpace Cognition in patients with MCI.
Publisher
Cold Spring Harbor Laboratory
Reference39 articles.
1. Current advances in digital cognitive assessment for preclinical alzheimer’s disease;Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring,2021
2. Philips intellispace cognition digital test battery: equivalence and measurement invariance compared to traditional analog test versions;The Clinical Neuropsychologist,2021
3. Stefan Vermeent , Ron Dotsch , Ben Schmand , Laura Klaming , Justin B. Miller , and Gijs van Elswijk . Evidence of validity for a newly developed digital cognitive test battery. Frontiers in Psychology, 11, 2020.
4. Mild Cognitive Impairment